These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Heart; 1998 Apr 01; 79(4):331-6. PubMed ID: 9616338 [Abstract] [Full Text] [Related]
10. Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Jalanko M, Tarkiainen M, Sipola P, Jääskeläinen P, Lauerma K, Laine M, Nieminen MS, Laakso M, Heliö T, Kuusisto J. Ann Med; 2016 Sep 01; 48(6):417-427. PubMed ID: 27249556 [Abstract] [Full Text] [Related]
12. Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy. Nie C, Zhu C, Xiao M, Yang Q, Meng Y, Wu R, Wang S. Clin Cardiol; 2021 Apr 01; 44(4):555-562. PubMed ID: 33626191 [Abstract] [Full Text] [Related]
13. Clinical impact of nonsustained ventricular tachycardia recorded by the implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy. Francia P, Santini D, Musumeci B, Semprini L, Adduci C, Pagannone E, Proietti G, Volpe M, Autore C. J Cardiovasc Electrophysiol; 2014 Nov 01; 25(11):1180-7. PubMed ID: 25066044 [Abstract] [Full Text] [Related]
14. Reversed Septal Curvature Is Associated With Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy. He Y, Zhou J. Am J Cardiol; 2024 Jan 01; 210():195-200. PubMed ID: 37884111 [Abstract] [Full Text] [Related]